Roussakis, E. (2023) “Pharmaceutical Data Exclusivity in the Light of Access to Clinical Data: Is the EMA oversharing?”, Stockholm Intellectual Property Law Review , 6(2), pp. 25 – 34. doi: 10.53292/62cdf208.5b66823e.